the aid library

LIST OPTIONS

Filter

2807

Sort by:

Direction:

Download (155)

View PDF (227)

Evaluation of Infection Prevention and Control Readiness at Frontline Health Care Facilities in High-Risk Districts Bordering Ebola Virus Disease–Affected Areas in the DRCongo-Uganda 2018

Biedron, C.; M.Lyman, M.J. Stucke, et al. CDC (2019) C_CDC

Morbidity and Mortality Weekly Report (MMWR) October 4, 2019 / 68(39);851–854

Download (197)

View PDF (355)

Policy for Tuberculosis Control in Substance Abuse Treatment Centers

M. Botticelli (Bureau of Substance Abuse Services); K. Cranston, A. DeMaria (Bureau of Infectious Disease); et al. Massachusetts Department of Public Health (2009) C2

Download (1099)

View PDF (1453)

Tuberculosis Infection Control in the Era of Expanding HIV Care and Treatment: Addendum to WHO Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-limited Settings

Center for Disease Control and Prevention, World Health Organisation (2007)

The goal of this addendum is to help management and staff  minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,  and/or support, and b.) there is a high prevalence of HIV infection, both known  and... more

Download (253)

View PDF (360)

Rwanda: 2013-2014 ANNUAL REPORT - Tuberculosis, other respiratory communicable diseases and Leprosy control in Rwanda

Rwanda Biomedical Center - Institute of HIVAIDS, Disease prevention & Control (IHDPC), TB & Other Respiratory Communicable Diseases Division (2014) C2

This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018 ... more

Download (316)

View PDF (738)

NAMPHIA (Namibia Population-Based HIV Impact Assessment) Flyer

Ministry of Health and Social Services (MOHSS) , PEPFAR, Namibia Statistics Agency, Namibia Institute of Pathology Limited MHSS (2017) C2

The Namibia Population-based HIV Impact Assessment (NAMPHIA) 2017 | The Ministry of Health and Services is leading the NAMPHIA survey in collaboration with the Namibia Statistics Agency (NSA) and the Namibia Institute of Pathology (NIP). The survey is supported by the United States President’s Eme... more

Download (374)

View PDF (686)

NAMPHIA (Namibia Population-Based HIV Impact Assessment) Brochure

Ministry of Health and Social Services (MOHSS), PEPFAR, Namibia Statistics Agency, Namibia Institute of Pathology Limited MHSS (2017) C2

Download (431)

View PDF (355)

WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals

World Health Organization WHO (2019) C_WHO

Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med... more

Download (520)

View PDF (1224)

Zika. CDC Draft Interim Response Plan

Centers for Disease Prevention and Control CDC (2016) C_CDC

Download (328)

View PDF (487)

NAMPHIA (Namibia Population-Based HIV Impact Assessment) Poster

Ministry of Health and Social Services (MOHSS), PEPFAR, Namibia Statistics Agency, Namibia Institute of Pathology Limited MHSS (2017) C2

Download (226)

View PDF (344)

Rwanda: July 2014 – June 2015 Annual Report - Tuberculosis and Other Respiratory communicable Diseases Control in Rwanda

Rwanda Biomedical Center - Institute of HIVAIDS, Disease prevention & Control (IHDPC), TB & Other Respiratory Communicable Diseases Division (2015) C2

Download (109)

View PDF (1244)

Evaluation of the Tuberculosis Infection Control Training Center, Tajikistan, 2014–2015

Scott, C.; J.M.Mangan, Z. Tillova, et al. (2017) C2

The International Journal of Tuberculosis and Lung Disease 21(5) DOI: 10.5588/ijtld.16.0518

Download (92)

View PDF (148)

Belgian Antibiotic Policy Coordination Committee Policy paper for the 2014-2019 term

Erica Balligand, Michiel Costers and Evelyne Van Gastel Belgian Antibiotic Policy Coordination Committee (2014) C2

Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo... more

Download (79)

View PDF (1017)

Antimicrobial resistance surveillance in Africa: Successes, gaps and a roadmap for the future

Kariuki S., K. H. Keddy, M. Antonio AOSIS (2018) C2

Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat antimicrobial resistance (AMR). The Africa Centres fo... more

Download (61)

View PDF (83)

Global Adult Tobacco Survey: Executive Summary 2016

World Health Organization WHO (2016) C_WHO

Ethiopia GATS was implemented by Ethiopia Public Health Institute (EPHI) in collaboration with the Ethiopian Food, Medicine, Health Care Administration and Control Authority (FMHACA), CSA, FMOH and the World Health Organization (WHO)country office. Technical assistance ... more

Download (242)

View PDF (222)

Ensuring health security in the African region - Emergency preparedness and response flagship programmes

World Health Organization WHO, Regional Office of Africa (2022) C_WHO

The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship programmes to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the re... more

Download (112)

View PDF (144)

Network of WHO Collaborating centers for trachoma

World Health Organization WHO (2016) C_WHO

International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat... more

Download (109)

View PDF (129)

Ensuring health security in the African region: Emergency preparedness and response flagships progress report #4

World Health Organisation (WHO) (2022) C_WHO

The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship initiatives to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the r... more

Download (32)

View PDF (86)

Mpox Molecular Diagnostic Tests(RT-PCR)

Africa Center for Disease Control and Prevention (2024) CC

On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ... more

Download (28)

View PDF (35)

Asthma Action Plan - U.S. Centers for disease Control an Prevention

U. S. Centers for Disease Control and Prevention (2024) CC2

Asthma Action Plan Doctor’s Name: Doctor’s Phone Number: Main Emergency Contact: Backup Emergency Contact: Green Zone: No coughing, wheezing, chest tightness, or shortness of breath. Can do usual activities: Every day: Take these medicines, even if you’re not having any symptoms. Av... more

Download (6)

View PDF (5)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more